Mallampati score is a good and independent predictive factor for obstructive sleep apnoea (OSA)

published_or_final_versio

Lymphangioleimyomatosis: the Hong Kong experience

published_or_final_versio

Collaboration interface in Smart Metering Scheme

Theme: Towards a safe, reliable, sustainable intelligent power systemPaper no. I9FP0475Smart meter provides intelligence to serve demand side management. The development of electrical-load-signature technology provides an effective base to enable condition-based monitoring and energy-collaboration management among stakeholders. In a smart metering scheme, the three direct contributors are supplier, estate manager and consumer. Affiliated members are appliance manufacturers and sustainability managers. It is perceived that when a platform can be developed to permit members sharing information, trading benefits, and recommending energy plans. The development of a collaboration interface is to assist the principal members in supporting each other as neighboring aide in these activities. This paper discusses on philosophies and models that shall develop the concepts; and shares the development of this interface.postprintThe 15th International Conference on Electrical Engineering (ICEE 2009), Shenyang, China, 5-9 July 2009

Chemotherapy for advanced non-small-cell lung cancer: Role of paclitaxel and gemcitabine

Objective. To review the role of chemotherapy in advanced non-small-cell lung cancer, focusing on cisplatin-based regimens and two new drugs: paclitaxel and gemcitabine. Data sources. Medline search of the relevant English literature. Study selection. Open and randomised comparative (phases II and III) studies, and meta-analyses of cytotoxic drugs/regimens used to treat advanced non-small-cell lung cancer. Data extraction. The following factors were studied and compared: symptomatic response rates; tumour response rates; median survival time and 1-year survival rates; and side effects of cisplatin-, paclitaxel-, and gemcitabine-based regimens. Data synthesis. Using cisplatin-based chemotherapy achieves significant relief of disease-related symptoms of advanced non-small-cell lung cancer and a slight improvement in the median survival time (by approximately 1.5 months). New cytotoxic drugs that are effective and have good safety profiles include paclitaxel and gemcitabine. When used as single agents, these two drugs give response rates of approximately 25%. When used with cisplatin/carboplatin, response rates increase to 45% to 62% and 1-year survival rates increase to 40% to 60%. Conclusion. Paclitaxel, gemcitabine, and other drugs such as decetaxel and vinorelbine are promising new chemotherapeutic agents in the treatment of advanced non-small-cell lung cancer. These drugs can palliate disease symptoms and improve the median survival time. The optimal dose and treatment schedules, however, are yet to be defined.published_or_final_versio

Gastro-oesophageal reflux in bronchiectasis

published_or_final_versio

Gastro-oesophageal reflux in bronchiectasis

published_or_final_versio

Exhaled nitric oxide predicts lung function but not quality of life in subjects with non-small cell lung cancer

published_or_final_versio

Clinical predictors of sputum microbiology in chronic Chinese bronchiectasis

published_or_final_versio

Intelligent integration of BIPV and load management systems for modern buildings

This paper outlines the basics of load management, and highlights the possibility of maximising the contribution from the Building Integrated Photovoltaic (BIPV) power generation. It will also explain the underlying principles of a dynamic modelling approach and its application in supporting the anticipatory control strategy for load shifting. For many types of building applications, the load profiles are well matched with the BIPV generation profiles such that the BIPV power source is already acting as the peak clipping device. The application of Building Management Systems (BMS) in load shifting should consider the supply from BIPV system. Secondly, due to the thermal mass of the building, there exists time delay in the response of the power requirement of the HVAC system in the building from the solar radiation data. The BIPV system, on the contrary, is responding almost instantaneously to the solar irradiance. A dynamic BIPV model could be applied in aiding the prediction of the load profile. This paper will outline these aspects of the BIPV system as a demonstration of its application in BMS.postprintThe 8th Annual Power Symposium, Hong Kong, 19 June 2009

Integration of BIPV systems and load management

This paper outlines the basics of load management, and highlights the possibility of maximising the contribution from the Building Integrated Photovoltaic (BIPV) power generation. It will also explain the underlying principles of a dynamic modelling approach and its application in supporting the anticipatory control strategy for load shifting. For many types of building applications, the load profiles are well matched with the BIPV generation profiles such that the BIPV power source is already acting as the peak clipping device. The application of Building Management Systems (BMS) in load shifting should consider the supply from BIPV system. Secondly, due to the thermal mass of the building, there exists time delay in the response of the power requirement of the HVAC system in the building from the solar radiation data. The BIPV system, on the contrary, is responding almost instantaneously to the solar irradiance. A dynamic BIPV model could be applied in aiding the prediction of the load profile. This paper will outline these aspects of the dynamic model developed as a demonstration of its application.postprintThe International Conference on Electrical Engineering 2009